Outpatient parenteral antimicrobial-drug therapy

DN Gilbert, RJ Dworkin, SR Raber… - New England Journal …, 1997 - Mass Medical Soc
Over the past 20 years, outpatient parenteral therapy with antimicrobial drugs has proved
effective, safe, and cost effective for patients with a wide range of infectious diseases. – 4 …

[HTML][HTML] Late-occurring neurologic sequelae in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study

…, DC Bowers, A Yeaton-Massey, SH Raber… - Journal of Clinical …, 2010 - ncbi.nlm.nih.gov
… diagnosis onward, site of any tumor(s), and fields and doses of … , or inability to move arm(s)
or leg(s). An aggregate variable for … or inability to move arms(s) or leg(s). Reported decreased …

Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE …

…, S Jiménez-Jorge, G Turner, S Raber… - Journal of …, 2020 - academic.oup.com
… There were no confirmed Hy’s law cases (definition of Hy’s criteria provided in Text S1). …
criteria based on laboratory parameter assessment and none of which met Hy’s law criteria. …

Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience

…, S Duriseti, A Banerjee, T Nicolaides, S Raber… - Journal of neuro …, 2018 - Springer
… Here, we present our single institution’s experience using reRT and PD-1 inhibition with
nivolumab compared to reRT alone in patients with recurrent DIPG and as compared to those …

Pharmacodynamics of Glycopeptides in the Mouse Peritonitis Model of Streptococcus pneumoniae orStaphylococcus aureus Infection

JD Knudsen, K Fuursted, S Raber… - Antimicrobial agents …, 2000 - Am Soc Microbiol
… For S. pneumoniae, the ED 50 for different dosing regimens increased with the number of …
50 s for vancomycin and teicoplanin were 0.65 and 0.45 mg/kg, respectively, but the ED 50 s

National survey of extended-interval aminoglycoside dosing

SK Chuck, SR Raber, KA Rodvold… - Clinical infectious …, 2000 - academic.oup.com
A random sample survey of 500 acute care hospitals in the United States was conducted to
evaluate the adoption of extended-interval aminoglycoside dosing (EIAD). The survey …

Survivors of childhood cancer have increased risk of gastrointestinal complications later in life

R Goldsby, Y Chen, S Raber, L Li, K Diefenbach… - Gastroenterology, 2011 - Elsevier
… Surgeries performed for cancer treatment, site of tumor(s), and fields of radiation therapy
were recorded. Abdominal surgeries included those considered intra-abdominal by ICD-9 …

[HTML][HTML] Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trial

…, J Bukowski, H Li, SL Schulman, S Raber… - Arthritis Research & …, 2015 - Springer
Introduction Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis
(RA). During the clinical development programme, increases in mean serum creatinine (…

Pilot study of hyperpolarized 13C metabolic imaging in pediatric patients with diffuse intrinsic pontine glioma and other CNS cancers

…, HY Chen, JW Gordon, S Raber… - American Journal …, 2021 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Pediatric CNS tumors commonly present challenges for
radiographic interpretation on conventional MR imaging. This study sought to investigate the …

The effects of cyclosporine on the pharmacokinetics of doxorubicin in patients with small cell lung cancer

DA Rushing, SR Raber, KA Rodvold, SC Piscitelli… - Cancer, 1994 - Wiley Online Library
Background. The authors compared the pharmacokinetics of doxorubicin when administered
with and without concomitant high dose cyclosporine for multidrug resistant (MDR) tumor …